Deutsch English Français

Contact

EP3749370

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP3749370

EP3749370 - PHARMACEUTICAL FORMULATIONS, METHOD FOR PRODUCING A PHARMACEUTICAL FORMULATION AND A MEDICAMENT COMPRISING SAME [Right-click to bookmark this link]
Former [2020/51]	PHARMACEUTICAL FORMULATIONS, METHOD FOR PRODUCING A PHARMACEUTICAL FORMULATION, AND MEDICAMENT COMPRISING SAME
	[2021/35]
Status	Examination is in progress Status updated on 22.07.2022 Database last updated on 20.07.2024
Former	Request for examination was made Status updated on 13.11.2020
Former	The international publication has been made Status updated on 17.08.2019
Former	unknown Status updated on 14.02.2019
Most recent event Tooltip	28.02.2024	New entry: Renewal fee paid
Applicant(s)	For all designated states Smawa GmbH Nikolausstraße 18 97082 Würzburg / DE
	[2020/51]
Inventor(s)	01 / ROEWER, Norbert Nikolausstraße 18 97082 Würzburg / DE
	02 / BROSCHEIT, Jens Kerzenleite 35 97209 Würzburg / DE
	03 / STEER, Isabell Holsterhauser Str. 92 45147 Essen / DE
	[2020/51]
Representative(s)	Glawe, Delfs, Moll Partnerschaft mbB von Patent- und Rechtsanwälten Postfach 13 03 91 20103 Hamburg / DE
	[2020/51]
Application number, filing date	19702628.9	07.02.2019
	[2020/51]
	WO2019EP52972
Priority number, date	EP20180155542	07.02.2018 Original published format: EP 18155542
	[2020/51]
Filing language	DE
Procedural language	DE
Publication	Type:	A1 Application with search report
	No.:	WO2019154896
	Date:	15.08.2019
	Language:	DE
	[2019/33]
	Type:	A1 Application with search report
	No.:	EP3749370
	Date:	16.12.2020
	Language:	DE
	The application published by WIPO in one of the EPO official languages on 15.08.2019 takes the place of the publication of the European patent application.
	[2020/51]
Search report(s)	International search report - published on:	EP	15.08.2019
Classification	IPC:	A61K47/32, A61K47/38, A61K9/14, A61K9/51, A61K31/4985, A61K9/00	[2020/51]
	CPC:	A61K47/32 (EP,KR,US); A61K9/006 (EP,KR,US); A61K31/4985 (EP,KR,US); A61K47/10 (US); A61K47/20 (EP,KR,US); A61K47/38 (EP,US); (+) A61K9/0043 (KR,US); A61K9/0056 (EP); A61K9/10 (EP,KR,US); A61K9/2013 (EP,KR); A61K9/2027 (EP,KR); A61K9/2054 (EP,KR); A61K9/4858 (EP,KR); A61K9/4866 (EP,KR); A61P15/10 (KR,US) (-)
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/51]
Title	German:	PHARMAZEUTISCHE FORMULIERUNGEN, VERFAHREN ZUM HERSTELLEN EINER PHARMAZEUTISCHEN FORMULIERUNG SOWIE EIN ARZNEIMITTEL UMFASSEND EINE SOLCHE	[2020/51]
	English:	PHARMACEUTICAL FORMULATIONS, METHOD FOR PRODUCING A PHARMACEUTICAL FORMULATION AND A MEDICAMENT COMPRISING SAME	[2021/35]
	French:	FORMULATIONS PHARMACEUTIQUES, PROCÉDÉ DE PRÉPARATION D'UNE FORMULATION PHARMACEUTIQUE AINSI QUE MÉDICAMENT COMPRENANT UNE TELLE FORMULATION	[2021/35]
	Former [2020/51]	PHARMACEUTICAL FORMULATIONS, METHOD FOR PRODUCING A PHARMACEUTICAL FORMULATION, AND MEDICAMENT COMPRISING SAME
	Former [2020/51]	FORMULATIONS PHARMACEUTIQUES, PROCÉDÉ DE FABRICATION D'UNE FORMULATION PHARMACEUTIQUE ET MÉDICAMENT COMPRENANT UNE TELLE FORMULATION PHARMACEUTIQUE
Entry into regional phase	04.09.2020	National basic fee paid
	04.09.2020	Designation fee(s) paid
	04.09.2020	Examination fee paid
Examination procedure	04.09.2020	Examination requested [2020/51]
	04.09.2020	Date on which the examining division has become responsible
	17.11.2020	Amendment by applicant (claims and/or description)
	21.07.2022	Despatch of a communication from the examining division (Time limit: M04)
	17.11.2022	Reply to a communication from the examining division
Fees paid	Renewal fee
	15.04.2021	Renewal fee patent year 03
	21.02.2022	Renewal fee patent year 04
	22.02.2023	Renewal fee patent year 05
	28.02.2024	Renewal fee patent year 06
	Penalty fee
	Additional fee for renewal fee
	28.02.2021	03 M06 Fee paid on 15.04.2021
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[XI]US2007104792 (JENKINS SCOTT [US]) [X] 1-8,11,13-15 * paragraphs [0045] - [0050] - [0062] - [0066] - [0077] - [0086] - [0103] - [0111] - paragraphs [0121] - [0130] - [ 140] - [0172] * * example -; claim - * [I] 9,10,12,13;
		[A]EP1985310 (TEVA PHARMA [IL]) [A] 1-15 * example -; claim - * * paragraphs [0043] , [0080] - [0083] *;
		[A]US2011263606 (ZERBE HORST [CA], et al) [A] 1-15 * the whole document *;
		[A]WO2014003677 (XSPRAY MICROPARTICLES AB [SE]) [A] 1-15* the whole document *;
		[XI]US2015359735 (HERRY CATHERINE [FR], et al) [X] 1-8,11,14,15 * paragraphs [0001] - [0003] - [0010] - [0016] - [0 30] - [0060] * * example -; claim - * [I] 9,10,12,13
	by applicant	US2015359735
		- STEINER et al., "Efficient production of nanoparticle-loaded orodispersible films by process integration in a stirred media mill", International Journal of Pharmaceutics, (20160000), vol. 511, doi:doi:10.1016/j.ijpharm.2016.07.058, pages 804 - 813, XP029716316 DOI: http://dx.doi.org/10.1016/j.ijpharm.2016.07.058

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p